Emily de los Reyes
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Emily de los Reyes sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Emily de los Reyes: 4 sponsored US clinical trials, none currently recruiting.
Emily de los Reyes sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 1 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is CLN6, with 2 trials.
Upper-quartile sponsor footprint
Emily de los Reyes sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Long-Term Follow Up of CLN6 Batten Disease Subjects Following Gene Transfer
NCT04273243
Natural History of Neuronal Ceroid Lipofuscinosis, Batten's CLN6 Diseae
NCT03285425
Natural History Study of Batten Disease
NCT04644549
Gene Therapy For Children With Variant Late Infantile Neuronal Ceroid Lipofuscinosis 6 (vLINCL6) Disease
NCT02725580
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Therapeutic Areas
How the Emily de los Reyes early-phase archive is shaped
4 indexed studies, none listed as recruiting (0% open); 1 completed (25%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: CLN6 (2 trials), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Emily de los Reyes: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Emily de los Reyes sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Emily de los Reyes page
4 registered trials is a research-attention snapshot, not an endorsement of Emily de los Reyes or any single study.
- None of Emily de los Reyes's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- CLN6 is the condition Emily de los Reyes studies most, compare against other sponsors active in the same condition before evaluating a specific study. See CLN6 trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Emily de los Reyes pipeline card: 4 registered trials from official public datasets.Report a data error.